von Autenried Paul's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Aug 3, 2021
- Accession no.
- 0000014272-21-000192
- Filed
- Aug 3, 2021
- Trade date
- Jul 30, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.70M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| von Autenried PaulCIK 0001524143 | Officer (EVP, Chief Information Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Common Stock, $0.10 par value | SSaleDisposed | −25,000 | $68.06 | −$1,701,500 | 114,670.07 | Direct | |
| Jul 30, 2021 | Common Stock, $0.10 par value | GGiftDisposed | −114,670.07 | $0.00 | $0 | 0 | Direct | |
| Jul 30, 2021 | Common Stock, $0.10 par value | GGiftAcquired | +114,670.07 | $0.00 | $0 | 114,670.07 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.